Formosa

Taiyao Chemical was established in 1995 and entered the field of API production in 2000. With its strong research and development strength and solid quality system management, it has gradually shown its prominence in the biological pharmaceutical industry. Currently there are dozens of API products marketed worldwide. It also provides CDMO (Contract Development and Manufacturing Organization) services and Antibody-Drug conjugates (ADCs) development and manufacturing services.
Taiyao is ISO certifified, and successfully passed the GMP inspections of different institutes such as the Food and Drug Administration of Taiwan Ministry of Health and Welfare, FDA of the United States, BGV of Germany, EDQM of the European Union and PMDA of Japan. Under the requirements of cGMP, the company continuously updates and implements products in line with the current international good manufacturing practice standards, marketing API products, injection drugs and OEM business extends to various regions in Europe, the United States, Japan and all over the world.

Advantage products:

Product Name	Category	Characteristic & Application	CDMF status
Baisaiazide			Plan to declare

Back List